Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125908421 | 12590842 | 1 | I | 20120904 | 20121022 | 20160726 | 20160726 | EXP | GB-009507513-1210GBR010901 | MERCK | 48.00 | YR | M | Y | 0.00000 | 20160726 | CN | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125908421 | 12590842 | 1 | SS | PEGINTERFERON ALFA-2B | PEGINTERFERON ALFA-2B | 1 | Subcutaneous | UNK | U | 0 | POWDER FOR INJECTION | ||||||||
125908421 | 12590842 | 2 | PS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | UNK | U | 20903 | TABLET | ||||||||
125908421 | 12590842 | 3 | SS | TELAPREVIR | TELAPREVIR | 1 | 750 MG, TID | 191250 | MG | 0 | 750 | MG | TABLET | TID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125908421 | 12590842 | 2 | Hepatitis C |
125908421 | 12590842 | 3 | Hepatitis C |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125908421 | 12590842 | LT |
125908421 | 12590842 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125908421 | 12590842 | Myocardial infarction |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125908421 | 12590842 | 1 | 20120507 | 0 | ||
125908421 | 12590842 | 2 | 20120507 | 0 | ||
125908421 | 12590842 | 3 | 20120507 | 20120730 | 0 |